Xxera/openscience/retractions

Record #24981

The value of FGF9 as a novel biomarker in the diagnosis of prostate cancer

Genggang Cui, Mingming Shao, Xingzhou Gu, Hongbo Guo, Shiqing Zhang, Jianlei Lu, Hongbin Ma

Journal

Artificial Cells, Nanomedicine, and Biotechnology

Publisher

Taylor and Francis

Original paper date

Jun 7, 2019

Original DOI

10.1080/21691401.2019.1620250

Country

Institution

Department of Urology Surgery, The First People’s Hospital of Jining, Jining, Shandong, China · Department of Urology Surgery, Yanzhou Branch of Jining Medical University, Jining, Shandong, China

Open access

No

Article type

Research Article

Broad categories

(BLS) Biochemistry (BLS) Biology - Cancer (HSC) Medicine - Oncology (HSC) Medicine - Urology/Nephrology

Citation lifecycle

How this paper is being cited

Pre-retraction

3

Same day

0

Post-retraction

5

% post-retraction

62.5%

~1.9 citations/yr before retraction · ~0.9 citations/yr after

— citing papers

Who is still citing this work

Loading…